All posts
-
Novo Nordisk proposes Genmab CEO as new board member
The checklist of recommended board participants additionally consists of a Takeda exec with experience from Eli Lilly.
-
Rising Wegovy prescriptions don’t capture whole story, says analyst
Weekly development in Wegovy shots reveals tablet computers aren’t cannibalizing prescriptions.
-
Novo Nordisk sees continued boost in US sales of Wegovy tablet
New information reveals that Novo Nordisk released 52,299 brand-new prescriptions for the Wegovy tablet computer in the United States recently.
-
ALK’s Neffy launch delayed in Canada, Danish market set for March
The launch of ALK’s adrenaline sinus spray, Neffy, is taking much longer than anticipated, yet the firm is established for a prepared launch in Denmark simply nearby.
-
Medical device company admits to billion-dollar US health care fraud
Danish clinical gadget company Zynex, started by Thomas Sandgaard, resolves with United States authorities.
-
ALK’s leadership wanted Henriette Mersebach out to ensure “the right profile for next phases”
Nevertheless, the chief executive officer does not wish to define the separation of Henriette Mersebach, EVP of study, as a termination.
-
Genmab is convinced that pipeline will withstand looming patent gap
Adhering To the USD 8bn purchase of Merus, Genmab’s chief executive officer turns down more procurements in the coming years. “We do not require to,” states Jan v…
-
Sonova CEO sees solid growth in cosmetic hearing aid market following new launches
”When a small product comes along that looks cool and sounds good, it grows,” says Sonova CEO.
-
Content marketing jobs are splitting in two
A Semrush research study of 8,000 work listings reveals web content functions polarizing in between hands on designers and elderly development proprietors.The article Material adve…
-
The HubSpot updates you don’t want to miss from January 2026
Just how do cleaner process, smarter sectors and much less hands-on cleaning audio to you?The article The HubSpot updates you do not intend to miss out on from January 2026 showed …
